Bartholomew Price

I am working in Specialist Eye Hospital and ( Bevacizumb) is one of the main anti-VEGF medication with high daily consumption
Yet, it is off labels use for AMD but it has a satisfactory safety profile so far and more cost saving compering to the other approved anti-VEGF
We prepared it in the IV room under standard aseptic techniques at dose 1.25mg/0.5ml is intravitreal injection and at 2.5mg/ml as subconjunctival injection

If you need more information I will be more than happy to assist


This website uses cookies to improve your experience. By using this website you agree to our Cookie Policy.
Read more